annual EBITDA:
$1.14B+$75.26M(+7.05%)Summary
- As of today (May 29, 2025), RDY annual EBITDA is $1.14 billion, with the most recent change of +$75.26 million (+7.05%) on March 1, 2025.
- During the last 3 years, RDY annual EBITDA has risen by +$538.21 million (+88.94%).
- RDY annual EBITDA is now at all-time high.
Performance
RDY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$291.56M+$4.18M(+1.45%)Summary
- As of today (May 29, 2025), RDY quarterly EBITDA is $291.56 million, with the most recent change of +$4.18 million (+1.45%) on March 1, 2025.
- Over the past year, RDY quarterly EBITDA has increased by +$46.86 million (+19.15%).
- RDY quarterly EBITDA is now at all-time high.
Performance
RDY quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.12B+$46.86M(+4.35%)Summary
- As of today (May 29, 2025), RDY TTM EBITDA is $1.12 billion, with the most recent change of +$46.86 million (+4.35%) on March 1, 2025.
- Over the past year, RDY TTM EBITDA has increased by +$70.89 million (+6.73%).
- RDY TTM EBITDA is now at all-time high.
Performance
RDY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RDY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.0% | +19.1% | +6.7% |
| 3 y3 years | +88.9% | +82.9% | +63.3% |
| 5 y5 years | +157.9% | +104.8% | +152.9% |
RDY EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +88.9% | at high | +82.9% | at high | +63.3% |
| 5 y | 5-year | at high | +157.9% | at high | +245.2% | at high | +159.3% |
| alltime | all time | at high | +4918.3% | at high | +273.6% | at high | +1207.1% |
RDY EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $1.14B(+7.0%) | $291.56M(+1.5%) | $1.12B(+4.3%) |
| Dec 2024 | - | $287.39M(+0.7%) | $1.08B(+1.7%) |
| Sep 2024 | - | $285.28M(+9.6%) | $1.06B(+0.4%) |
| Jun 2024 | - | $260.39M(+6.4%) | $1.06B(+0.2%) |
| Mar 2024 | $1.07B(+15.1%) | $244.71M(-9.1%) | $1.05B(+4.0%) |
| Dec 2023 | - | $269.27M(-4.3%) | $1.01B(+2.6%) |
| Sep 2023 | - | $281.50M(+9.0%) | $988.22M(+3.8%) |
| Jun 2023 | - | $258.24M(+26.3%) | $951.73M(+2.6%) |
| Mar 2023 | $928.35M(+53.4%) | $204.50M(-16.2%) | $927.46M(+5.1%) |
| Dec 2022 | - | $243.98M(-0.4%) | $882.41M(+8.9%) |
| Sep 2022 | - | $245.00M(+4.7%) | $810.52M(+3.9%) |
| Jun 2022 | - | $233.98M(+46.7%) | $780.10M(+13.3%) |
| Mar 2022 | $605.16M(+12.0%) | $159.45M(-7.3%) | $688.81M(+4.1%) |
| Dec 2021 | - | $172.09M(-19.8%) | $661.38M(+15.3%) |
| Sep 2021 | - | $214.58M(+50.4%) | $573.75M(+9.9%) |
| Jun 2021 | - | $142.69M(+8.1%) | $522.09M(-3.1%) |
| Mar 2021 | $540.24M(+21.8%) | $132.01M(+56.3%) | $539.04M(-1.9%) |
| Dec 2020 | - | $84.47M(-48.2%) | $549.37M(+25.9%) |
| Sep 2020 | - | $162.92M(+2.1%) | $436.33M(+0.6%) |
| Jun 2020 | - | $159.64M(+12.2%) | $433.73M(-2.4%) |
| Mar 2020 | $443.39M(-12.7%) | $142.34M(-598.2%) | $444.60M(+5.4%) |
| Dec 2019 | - | -$28.57M(-117.8%) | $422.02M(-26.9%) |
| Sep 2019 | - | $160.32M(-6.0%) | $577.47M(+5.9%) |
| Jun 2019 | - | $170.50M(+42.4%) | $545.23M(+11.2%) |
| Mar 2019 | $507.79M(+22.0%) | $119.76M(-5.6%) | $490.35M(+7.0%) |
| Dec 2018 | - | $126.88M(-0.9%) | $458.31M(-3.0%) |
| Sep 2018 | - | $128.08M(+10.8%) | $472.38M(+4.1%) |
| Jun 2018 | - | $115.63M(+31.8%) | $453.81M(+14.3%) |
| Mar 2018 | $416.30M(+5.1%) | $87.72M(-37.8%) | $396.88M(-1.4%) |
| Dec 2017 | - | $140.95M(+28.7%) | $402.37M(+2.0%) |
| Sep 2017 | - | $109.51M(+86.6%) | $394.60M(+2.0%) |
| Jun 2017 | - | $58.70M(-37.0%) | $386.80M(-2.3%) |
| Mar 2017 | $396.14M(-32.2%) | $93.21M(-30.0%) | $395.89M(+2.7%) |
| Dec 2016 | - | $133.18M(+30.9%) | $385.54M(-5.7%) |
| Sep 2016 | - | $101.71M(+50.0%) | $408.88M(-16.3%) |
| Jun 2016 | - | $67.79M(-18.2%) | $488.62M(-16.7%) |
| Mar 2016 | $584.20M(-4.4%) | $82.86M(-47.1%) | $586.81M(-8.3%) |
| Dec 2015 | - | $156.52M(-13.7%) | $639.77M(-2.2%) |
| Sep 2015 | - | $181.44M(+9.3%) | $654.01M(+4.8%) |
| Jun 2015 | - | $165.99M(+22.2%) | $623.81M(+2.1%) |
| Mar 2015 | $611.10M(+5.2%) | $135.82M(-20.5%) | $610.85M(+0.0%) |
| Dec 2014 | - | $170.75M(+12.9%) | $610.57M(-0.6%) |
| Sep 2014 | - | $151.25M(-1.2%) | $614.19M(-1.1%) |
| Jun 2014 | - | $153.02M(+12.9%) | $620.74M(+7.9%) |
| Mar 2014 | $580.63M(+11.7%) | $135.54M(-22.3%) | $575.40M(-6.8%) |
| Dec 2013 | - | $174.37M(+10.5%) | $617.57M(+10.6%) |
| Sep 2013 | - | $157.80M(+46.5%) | $558.58M(+5.7%) |
| Jun 2013 | - | $107.68M(-39.4%) | $528.66M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | $519.65M(+0.2%) | $177.71M(+54.0%) | $519.34M(+22.2%) |
| Dec 2012 | - | $115.38M(-9.8%) | $425.04M(-14.0%) |
| Sep 2012 | - | $127.88M(+30.0%) | $494.06M(+2.8%) |
| Jun 2012 | - | $98.37M(+17.9%) | $480.54M(+0.9%) |
| Mar 2012 | $518.60M(+40.3%) | $83.41M(-54.8%) | $476.48M(-4.5%) |
| Dec 2011 | - | $184.41M(+61.3%) | $498.74M(+23.5%) |
| Sep 2011 | - | $114.35M(+21.3%) | $403.79M(+5.5%) |
| Jun 2011 | - | $94.31M(-10.8%) | $382.78M(+3.5%) |
| Mar 2011 | $369.53M(+165.8%) | $105.67M(+18.1%) | $369.72M(+11.1%) |
| Dec 2010 | - | $89.46M(-4.2%) | $332.90M(+139.3%) |
| Sep 2010 | - | $93.34M(+14.9%) | $139.09M(+11.1%) |
| Jun 2010 | - | $81.25M(+18.0%) | $125.17M(-7.4%) |
| Mar 2010 | $139.03M(+329.4%) | $68.85M(-166.0%) | $135.18M(-233.1%) |
| Dec 2009 | - | -$104.35M(-231.4%) | -$101.58M(-200.9%) |
| Sep 2009 | - | $79.42M(-13.0%) | $100.71M(+17.1%) |
| Jun 2009 | - | $91.27M(-154.4%) | $86.01M(+66.5%) |
| Mar 2009 | $32.38M(-82.2%) | -$167.92M(-271.5%) | $51.66M(-81.7%) |
| Dec 2008 | - | $97.94M(+51.3%) | $282.47M(+69.2%) |
| Sep 2008 | - | $64.72M(+13.7%) | $166.96M(+1.6%) |
| Jun 2008 | - | $56.92M(-9.5%) | $164.29M(-9.9%) |
| Mar 2008 | $182.31M(-42.4%) | $62.89M(-457.9%) | $182.44M(-15.8%) |
| Dec 2007 | - | -$17.57M(-128.3%) | $216.60M(-27.0%) |
| Sep 2007 | - | $62.05M(-17.3%) | $296.91M(-11.3%) |
| Jun 2007 | - | $75.07M(-22.7%) | $334.67M(+5.9%) |
| Mar 2007 | $316.67M(+363.2%) | $97.05M(+54.7%) | $315.92M(+41.2%) |
| Dec 2006 | - | $62.73M(-37.2%) | $223.80M(+20.5%) |
| Sep 2006 | - | $99.82M(+77.2%) | $185.72M(+69.5%) |
| Jun 2006 | - | $56.32M(+1042.3%) | $109.58M(+61.7%) |
| Mar 2006 | $68.37M(+200.1%) | $4.93M(-80.0%) | $67.78M(+18.9%) |
| Dec 2005 | - | $24.66M(+4.2%) | $57.02M(+55.8%) |
| Sep 2005 | - | $23.67M(+63.1%) | $36.60M(+20.7%) |
| Jun 2005 | - | $14.51M(-349.1%) | $30.31M(+29.6%) |
| Mar 2005 | $22.78M(-67.5%) | -$5.83M(-237.5%) | $23.38M(-20.5%) |
| Dec 2004 | - | $4.24M(-75.6%) | $29.41M(-33.3%) |
| Sep 2004 | - | $17.39M(+129.2%) | $44.08M(-17.8%) |
| Jun 2004 | - | $7.59M(+3725.2%) | $53.63M(-23.1%) |
| Mar 2004 | $70.02M(-22.1%) | $198.30K(-99.0%) | $69.71M(-19.3%) |
| Dec 2003 | - | $18.90M(-29.8%) | $86.37M(+0.6%) |
| Sep 2003 | - | $26.95M(+13.9%) | $85.85M(+3.6%) |
| Jun 2003 | - | $23.66M(+40.3%) | $82.91M(-7.7%) |
| Mar 2003 | $89.86M(-28.5%) | $16.86M(-8.3%) | $89.79M(-6.1%) |
| Dec 2002 | - | $18.39M(-23.4%) | $95.63M(-15.2%) |
| Sep 2002 | - | $24.00M(-21.4%) | $112.83M(-19.7%) |
| Jun 2002 | - | $30.54M(+34.5%) | $140.43M(+11.7%) |
| Mar 2002 | $125.73M(+141.7%) | $22.70M(-36.2%) | $125.73M(+22.0%) |
| Dec 2001 | - | $35.59M(-31.0%) | $103.03M(+52.8%) |
| Sep 2001 | - | $51.60M(+225.7%) | $67.44M(+325.7%) |
| Jun 2001 | - | $15.84M | $15.84M |
| Mar 2001 | $52.01M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual EBITDA?
- What is the all time high annual EBITDA for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual EBITDA year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly EBITDA?
- What is the all time high quarterly EBITDA for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly EBITDA year-on-year change?
- What is Dr Reddys Laboratories Limited TTM EBITDA?
- What is the all time high TTM EBITDA for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM EBITDA year-on-year change?
What is Dr Reddys Laboratories Limited annual EBITDA?
The current annual EBITDA of RDY is $1.14B
What is the all time high annual EBITDA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual EBITDA is $1.14B
What is Dr Reddys Laboratories Limited annual EBITDA year-on-year change?
Over the past year, RDY annual EBITDA has changed by +$75.26M (+7.05%)
What is Dr Reddys Laboratories Limited quarterly EBITDA?
The current quarterly EBITDA of RDY is $291.56M
What is the all time high quarterly EBITDA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly EBITDA is $291.56M
What is Dr Reddys Laboratories Limited quarterly EBITDA year-on-year change?
Over the past year, RDY quarterly EBITDA has changed by +$46.86M (+19.15%)
What is Dr Reddys Laboratories Limited TTM EBITDA?
The current TTM EBITDA of RDY is $1.12B
What is the all time high TTM EBITDA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM EBITDA is $1.12B
What is Dr Reddys Laboratories Limited TTM EBITDA year-on-year change?
Over the past year, RDY TTM EBITDA has changed by +$70.89M (+6.73%)